MIRA Pharmaceuticals, Inc. (MIRA)
0.7054
-0.04
(-5.38%)
USD |
NASDAQ |
Oct 12, 16:00
0.70
-0.01
(-0.77%)
After-Hours: 20:00
MIRA Pharmaceuticals Net Income (Quarterly) : -1.208M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.208M |
| March 31, 2026 | -1.150M |
| December 31, 2025 | -5.983M |
| September 30, 2025 | -22.69M |
| June 30, 2025 | -1.538M |
| March 31, 2025 | -1.784M |
| December 31, 2024 | -2.400M |
| September 30, 2024 | -2.044M |
| June 30, 2024 | -1.691M |
| March 31, 2024 | -1.718M |
| Date | Value |
|---|---|
| December 31, 2023 | -5.787M |
| September 30, 2023 | -3.588M |
| June 30, 2023 | -1.266M |
| March 31, 2023 | -1.341M |
| December 31, 2022 | -1.350M |
| September 30, 2022 | -1.811M |
| June 30, 2022 | -2.423M |
| March 31, 2022 | -1.475M |
| March 31, 2021 | -0.057M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Resonate Blends, Inc. | -0.9669M |
| Breakthrough Chemistry, Inc. | -1.083M |
| Kaya Holdings, Inc. | -8.592M |
| Cardiac Biotech Solutions, Inc. | -0.1372M |
| Endexx Corp. | -1.288M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.208M |
| EPS Diluted (Quarterly) | -0.0288 |
| Enterprise Value | 21.53M |
| Earnings Yield | -195.1% |
| Normalized Earnings Yield | -195.08 |